Medical information affecting clinical practice can change rapidly as new scientific research is published and new treatment therapies are approved.
As a clearinghouse for the latest thrombosis and anticoagulation information, the content on the ClotConnect.org website is under constant update.
Recent revisions include:
- Prescription Assistance: Patients who have been prescribed Xarelto (rivaroxaban) and have difficulty affording their medication, may be eligible for prescription assistance through a variety of options, including a discount savings card. Information on Xarelto assistance is available online at this link or by calling 1-888-XARELTO (1-888-927-3586), Monday - Friday, 8:00 AM - 8:00 PM ET. Prescription drug assistance programs for other drugs can be found on the Clot Connect website, here.
- Aspirin and clot prevention: A November 2012 blog post on the topic of "Does aspirin prevent VTE" has been revised to reflect newly information learned from recently published studies. The post for patients, available here. The post forhealthcare professionals here.
- Ischemic Colitis and thrombophilia: A July 2012 post has been updated for patients and healthcare professionals to reflect current clinical guidance regarding ischemic colitis and thrombophilia.
- Paroxysmal nocturnal hemoglobinuria (PNH): PNH is a serious, but rare, disease that can cause thrombosis. Links to information on this condition have been added, here.
- Newly Diagnosed with DVT or PE: The brochure for patients newly diagnosed with blood clots has been revised to reflect the approval of Xarelto for the treatment of DVT/PE and to clarify the latest guidance on the use of compression stockings to manage post-thrombotic syndrome. The brochure is available on the clotconnect.org website, here.